Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

HJ Forman, H Zhang - Nature Reviews Drug Discovery, 2021 - nature.com
Oxidative stress is a component of many diseases, including atherosclerosis, chronic
obstructive pulmonary disease, Alzheimer disease and cancer. Although numerous small …

KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

E Crisman, P Duarte, E Dauden… - Medicinal research …, 2023 - Wiley Online Library
The transcription factor nuclear factor erythroid 2‐related factor 2 (NRF2) is considered the
master regulator of the phase II antioxidant response. It controls a plethora of cytoprotective …

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

EL Mills, DG Ryan, HA Prag, D Dikovskaya, D Menon… - Nature, 2018 - nature.com
The endogenous metabolite itaconate has recently emerged as a regulator of macrophage
function, but its precise mechanism of action remains poorly understood,,. Here we show …

Coupling Krebs cycle metabolites to signalling in immunity and cancer

DG Ryan, MP Murphy, C Frezza, HA Prag… - Nature …, 2019 - nature.com
Metabolic reprogramming has become a key focus for both immunologists and cancer
biologists, with exciting advances providing new insights into the mechanisms underlying …

The role of astrocytes in multiple sclerosis

G Ponath, C Park, D Pitt - Frontiers in immunology, 2018 - frontiersin.org
The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS)
lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes …

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL

A Schmitt, W Xu, P Bucher, M Grimm… - Blood, The Journal …, 2021 - ashpublications.org
Despite the development of novel targeted drugs, the molecular heterogeneity of diffuse
large B-cell lymphoma (DLBCL) still poses a substantial therapeutic challenge. DLBCL can …

Tricarboxylic acid (TCA) cycle intermediates: regulators of immune responses

I Choi, H Son, JH Baek - Life, 2021 - mdpi.com
The tricarboxylic acid cycle (TCA) is a series of chemical reactions used in aerobic
organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from …

Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS)

S Glatigny, E Bettelli - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Multiple sclerosis (MS) is a multifocal demyelinating disease of the central nervous system
(CNS) leading to the progressive destruction of the myelin sheath surrounding axons. It can …

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

U Schulze-Topphoff, M Varrin-Doyer… - Proceedings of the …, 2016 - National Acad Sciences
Dimethyl fumarate (DMF)(BG-12, Tecfidera) is a fumaric acid ester (FAE) that was advanced
as a multiple sclerosis (MS) therapy largely for potential neuroprotection as it was …

The immunomodulatory potential of the metabolite itaconate

A Hooftman, LAJ O'Neill - Trends in immunology, 2019 - cell.com
The field of immunometabolism has demonstrated that metabolites can lead double lives as
immunomodulators. Itaconate is perhaps the best example of such a moonlighting molecule …